Skip to content
value.today
Codexis, Inc. logo

Codexis, Inc.

CDXS
$140 Mmarket cap on Oct 26, 2026-31.6% since Jan 2024
Compare
World rank
#17,521
Revenue
$70 M
For year ending December-2025
Net income
$-44 M
-62.5% margin
SEC filing
Employees
261
As on 2021
value.today research

Codexis, Inc. in brief

Codexis, Inc. is a listed company in the Biotechnology industry, based in Redwood City, California, USA. It was founded in 2002. Its market value was $140 M on 26 October 2026, which makes it the 17,521st largest listed company in the world and the 3,338th largest in the USA on this site. In the year to December 2025 it had sales of $70 M and a net loss of $44 M. It employs about 261 people and Alison Moore is its chief executive. Its largest product and service lines by sales in 2025 were Research and development revenue (63%). By market, the largest shares of its 2025 sales came from Americas (62%), USA (62%) and APAC (25%). Its shares trade under the symbol CDXS (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Codexis, Inc.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Codexis, Inc. timeline

5 events, 2002–2022
  1. 2002
  2. 🏁
    · approximate
    Founded
  3. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  4. 2010
  5. 🔔
    · approximate
    Initial public offering on Nasdaq as CDXS
  6. 2015
  7. •
    Legal Entity Identifier issued
    LEI 549300KGLM6CDPTVSE20 registered.
  8. 2022
  9. 💰
    Record revenue of $139 million
    FY2022, the highest of the 8 years on record.

Events of Codexis, Inc. from Wikidata, SEC EDGAR, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$448 M$897 M$1.3 B$1.8 B2020202120222023202420252026

World rank over time

▼ down 9,623 places since 2020
2020-01-01: #7930#7,93020202021-01-01: #6667#6,66720212022-01-07: #7037#7,03720222022-12-25: #15930#15,93020222023-07-30: #16894#16,89420232024-01-05: #17754#17,75420242026-03-08: #9823#9,82320262026-08-01: #15865#15,86520262026-10-14: #17489#17,48920262026-10-26: #17553#17,5532026

Rank in USA: #1,994 (Jan 2020) · #1,916 (Jan 2021) · #2,032 (Jan 2022) · #3,268 (Dec 2022) · #3,420 (Jul 2023) · #3,234 (Jan 2024) · #1,915 (Mar 2026) · #3,176 (Aug 2026) · #3,298 (Oct 2026) · #3,342 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
1.6×
Price / book
2.8×
Free cash flow yield
-17.0%
Net margin (TTM)
-21.8%
Operating margin
-59.3%
Return on equity
-38.0%
Liabilities / assets
65.8%
Net debt
$-11M
Revenue growth
+18.6%
R&D / revenue
74.3%
Revenue per employee
$270 K
Profit per employee
$-168 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $61M, net income $-11M$61MFY18Fiscal year ending Dec 2019: revenue $68M, net income $-12M$68MFY19Fiscal year ending Dec 2020: revenue $69M, net income $-24M$69MFY20Fiscal year ending Dec 2021: revenue $105M, net income $-21M$105MFY21Fiscal year ending Dec 2022: revenue $139M, net income $-34M$139MFY22Fiscal year ending Dec 2023: revenue $70M, net income $-76M$70MFY23Fiscal year ending Dec 2024: revenue $59M, net income $-65M$59MFY24Fiscal year ending Dec 2025: revenue $70M, net income $-44M$70MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$70M+18.6%$-42M$-44M-62.5%
Dec 2024$59M-15.4%$-59M$-65M-110.0%
Dec 2023$70M-49.4%$-68M$-76M-108.7%
Dec 2022$139M+32.3%$-35M$-34M-24.2%
Dec 2021$105M+51.7%$-23M$-21M-20.3%
Dec 2020$69M+0.9%$-24M$-24M-34.8%
Dec 2019$68M+13.0%$-13M$-12M-17.4%
Dec 2018$61M—$-11M$-11M-18.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-19M$4M$-24M$-0.50—
Dec 2024$-49M$4M$-54M$-0.89—
Dec 2023$-53M$4M$-57M$-1.12—
Dec 2022$11M$8M$3M$-0.51—
Dec 2021$-14M$14M$-28M$-0.33—
Dec 2020$-16M$4M$-20M$-0.40—
Dec 2019$-13M$4M$-16M$-0.21—
Dec 2018$-14M$3M$-17M$-0.21—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$88M
Net income, trailing 12 months
$-19M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $21M, net income $-10M$21MDec ’24Three months to Mar 2025: revenue $8M, net income $-21M$8MMar ’25Three months to Jun 2025: revenue $15M, net income $-13M$15MJun ’25Three months to Sep 2025: revenue $9M, net income $-20M$9MSep ’25Three months to Dec 2025 (from the annual report): revenue $39M, net income $10M$39MDec ’25Three months to Mar 2026: revenue $15M, net income $-9M$15MMar ’26Three months to Jun 2026: revenue $15M, net income $-12M$15MJun ’26Three months to Sep 2026: revenue $19M, net income $-8M$19MSep ’26

Latest quarter to Sep 2026: revenue $19M (+124.0% on a year earlier), net income $-8M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Codexis, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$70 M
Operating income
$-42 M
Net income
$-44 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$148 M
Total liabilities
$97 M
Total equity
$51 M

As of December-2025

Top 100 institutional investors in Codexis, Inc.#

As of Sep 30, 2026
130 institutions held 75.2 M shares (about 68.6% of the shares outstanding) on Sep 30, 2026. The ten largest hold 44.3%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Codexis, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Aberdeen Group plc10,797,702+4,027,748 (+59.49%)9.85%$15 MNov 10, 2026
2BlackRock, Inc.8,314,154+1,029,802 (+14.14%)7.59%$12 MNov 13, 2026
3Telemark Asset Management, LLC7,846,411+4,000,000 (+103.99%)7.16%$11 MNov 10, 2026
4Millennium Management LLC4,769,627-779,512 (-14.05%)4.35%$7 MNov 16, 2026
5Vanguard Capital Management LLC4,344,228+727,119 (+20.10%)3.96%$6 MNov 13, 2026
6Ameriprise Financial Inc3,055,267-754,173 (-19.80%)2.79%$4 MNov 16, 2026
7Nantahala Capital Management, LLC2,597,869-4,649,357 (-64.15%)2.37%$4 MNov 13, 2026
8Opaleye Management Inc.2,590,000-4,195,000 (-61.83%)2.36%$4 MNov 16, 2026
9Geode Capital Management, LLC2,472,631+310,238 (+14.35%)2.26%$3 MNov 6, 2026
10D. E. Shaw & Co., Inc.1,786,025+444,011 (+33.09%)1.63%$2 MNov 16, 2026
11State Street Corp1,635,386-121,428 (-6.91%)1.49%$2 MNov 12, 2026
12Jacobs Levy Equity Management, Inc1,543,312+213,107 (+16.02%)1.41%$2 MNov 16, 2026
13Vanguard Portfolio Management LLC1,425,324+118,153 (+9.04%)1.30%$2 MNov 13, 2026
14Private Advisor Group, LLC1,206,163New1.10%$2 MNov 10, 2026
15Acadian Asset Management LLC1,113,604+755,319 (+210.82%)1.02%$2 MNov 9, 2026
16Perkins Capital Management Inc1,021,850+495,750 (+94.23%)0.93%$1 MNov 2, 2026
17Two Sigma Investments, LP972,865+276,266 (+39.66%)0.89%$1 MNov 16, 2026
18Goldman Sachs Group Inc840,866+405,942 (+93.34%)0.77%$1 MNov 16, 2026
19Northern Trust Corp822,353+139,413 (+20.41%)0.75%$1 MNov 16, 2026
20Man Group plc786,317+220,724 (+39.03%)0.72%$1 MNov 16, 2026
21AQR Capital Management LLC769,535-75,896 (-8.98%)0.70%$1 MNov 16, 2026
22Morgan Stanley767,943+118,773 (+18.30%)0.70%$1 MNov 13, 2026
23Franklin Templeton Inc732,767+54,127 (+7.98%)0.67%$1 MNov 12, 2026
24Vanguard Fiduciary Trust Co712,294+131,236 (+22.59%)0.65%$1 MNov 13, 2026
25Stonepine Capital Management, LLC676,973+567,311 (+517.33%)0.62%$1 MNov 13, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Codexis, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Post Resch Tallon Group Inc.573,953+10,475 (+1.86%)0.52%$1 MOct 9, 2026
27Arrowstreet Capital, Limited Partnership536,983+388,932 (+262.70%)0.49%$1 MNov 13, 2026
28Los Angeles Capital Management LLC490,937+442,812 (+920.13%)0.45%$1 MNov 12, 2026
29FMR LLC486,907+8,424 (+1.76%)0.44%$1 MNov 10, 2026
30Bank Of America Corp /de/474,079+233,562 (+97.11%)0.43%$1 MNov 16, 2026
31Gsa Capital Partners LLP467,138+425,327 (+1017.26%)0.43%$1 MNov 16, 2026
32Assenagon Asset Management S.A.463,055-2,093,357 (-81.89%)0.42%$1 MOct 15, 2026
33Citadel Advisors LLC451,630+260,050 (+135.74%)0.41%$1 MNov 16, 2026
34XTX Topco Ltd438,691+198,064 (+82.31%)0.40%$1 MNov 16, 2026
35Price T Rowe Associates Inc /MD/421,336+354,412 (+529.57%)0.38%$1 MNov 16, 2026
36Royal Bank Of Canada403,131+140,205 (+53.32%)0.37%$1 MNov 16, 2026
37Prescott Group Capital Management, L.L.C.400,000New0.36%$1 MOct 30, 2026
38UBS Group AG359,427+119,520 (+49.82%)0.33%$0 MNov 10, 2026
39Tudor Investment Corp Et Al357,9250 (0.00%)0.33%$0 MNov 16, 2026
40Nuveen, LLC314,618-77,649 (-19.79%)0.29%$0 MNov 10, 2026
41Potomac Capital Management, Inc.310,000+50,000 (+19.23%)0.28%$0 MNov 13, 2026
42Russell Investments Group, Ltd.308,332+237 (+0.08%)0.28%$0 MNov 6, 2026
43Charles Schwab Investment Management Inc296,325+54,114 (+22.34%)0.27%$0 MNov 16, 2026
44Graham Capital Management, L.P.277,230+265,156 (+2196.09%)0.25%$0 MNov 16, 2026
45Bank of New York Mellon Corp250,632+24,593 (+10.88%)0.23%$0 MNov 5, 2026
46Algert Global LLC218,050-212,860 (-49.40%)0.20%$0 MNov 17, 2026
47Dimensional Fund Advisors LP201,464-111,922 (-35.71%)0.18%$0 MNov 4, 2026
48Invesco Ltd.198,321+36,050 (+22.22%)0.18%$0 MNov 12, 2026
49Barclays PLC187,238+31,964 (+20.59%)0.17%$0 MNov 6, 2026
50Strs Ohio169,800+48,800 (+40.33%)0.15%$0 MOct 30, 2026
51Squarepoint Ops LLC160,028New0.15%$0 MNov 9, 2026
52Prudential Financial Inc156,175+129,795 (+492.02%)0.14%$0 MNov 16, 2026
53Renaissance Technologies LLC130,935+89,435 (+215.51%)0.12%$0 MNov 12, 2026
54Alliancebernstein L.P.126,4300 (0.00%)0.12%$0 MNov 16, 2026
55Panagora Asset Management Inc124,551+66,351 (+114.01%)0.11%$0 MNov 12, 2026
56Bridgeway Capital Management, LLC123,980-1,928 (-1.53%)0.11%$0 MNov 16, 2026
57Canada Pension Plan Investment Board120,100New0.11%$0 MNov 16, 2026
58Empowered Funds, LLC115,072New0.10%$0 MNov 13, 2026
59Rhumbline Advisers98,249-5,052 (-4.89%)0.09%$0 MNov 10, 2026
60Deutsche Bank AG\84,357-11,872 (-12.34%)0.08%$0 MNov 6, 2026
61Citigroup Inc77,471+34,138 (+78.78%)0.07%$0 MNov 4, 2026
62LPL Financial LLC76,563+3 (0.00%)0.07%$0 MNov 6, 2026
63Quadrature Capital Ltd68,385+58,204 (+571.69%)0.06%$0 MNov 13, 2026
64Point72 Asset Management, L.P.65,969New0.06%$0 MNov 16, 2026
65Envestnet Asset Management Inc63,087+11,712 (+22.80%)0.06%$0 MNov 16, 2026
66Marshall Wace, LLP55,246-61,889 (-52.84%)0.05%$0 MNov 13, 2026
67Jpmorgan Chase & Co54,622+12,761 (+30.48%)0.05%$0 MNov 12, 2026
68Wells Fargo & Company/mn53,489-48,437 (-47.52%)0.05%$0 MNov 16, 2026
69MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.48,942+9,138 (+22.96%)0.04%$0 MNov 16, 2026
70BNP Paribas Financial Markets39,623+24,162 (+156.28%)0.04%$0 MNov 12, 2026
71Osaic Holdings, Inc.36,3660 (0.00%)0.03%$0 MNov 12, 2026
72Commonwealth Equity Services, LLC36,179-25 (-0.07%)0.03%$0 MNov 2, 2026
73Vanguard Global Advisers, LLC33,134+532 (+1.63%)0.03%$0 MNov 13, 2026
74Bank Of Montreal /can/31,661-3,337 (-9.53%)0.03%$0 MNov 9, 2026
75Krilogy Financial LLC30,141-4,684 (-13.45%)0.03%$0 MOct 13, 2026
76Aigen Investment Management, LP29,263New0.03%$0 MNov 16, 2026
77Evergreen Capital Management LLC29,0000 (0.00%)0.03%$0 MOct 23, 2026
78Capital Advisors, Ltd. LLC28,8900 (0.00%)0.03%$0 MOct 27, 2026
79Dynamic Technology Lab Private Ltd28,071-4,929 (-14.94%)0.03%$0 MNov 13, 2026
80Guggenheim Capital LLC26,391+233 (+0.89%)0.02%$0 MNov 16, 2026
81Axq Capital, LP24,863New0.02%$0 MNov 12, 2026
82Susquehanna International Group, LLP23,543-58,980 (-71.47%)0.02%$0 MNov 16, 2026
83Two Sigma Securities, LLC20,465New0.02%$0 MNov 16, 2026
84Blair William & Co/il20,000-10,219 (-33.82%)0.02%$0 MNov 10, 2026
85China Universal Asset Management Co., Ltd.19,981+5,515 (+38.12%)0.02%$0 MOct 28, 2026
86Police & Firemen's Retirement System of New Jersey19,4410 (0.00%)0.02%$0 MNov 9, 2026
87Voya Investment Management LLC18,5610 (0.00%)0.02%$0 MNov 10, 2026
88Vanguard Personalized Indexing Management, LLC17,862-86 (-0.48%)0.02%$0 MNov 16, 2026
89Tower Research Capital LLC (TRC)17,648+5,593 (+46.40%)0.02%$0 MNov 16, 2026
90Allspring Global Investments Holdings, LLC17,066+5,856 (+52.24%)0.02%$0 MNov 4, 2026
91New York State Common Retirement Fund16,8880 (0.00%)0.02%$0 MNov 17, 2026
92StoneX Group Inc.16,859New0.02%$0 MNov 3, 2026
93ProShare Advisors LLC16,636+2,333 (+16.31%)0.02%$0 MOct 29, 2026
94Engineers Gate Manager LP16,517New0.02%$0 MNov 16, 2026
95Navalign, LLC15,3400 (0.00%)0.01%$0 MNov 9, 2026
96Elmwood Wealth Management, Inc.12,6950 (0.00%)0.01%$0 MOct 14, 2026
97CIBC Bancorp USA Inc.11,911New0.01%$0 MNov 13, 2026
98Victory Capital Management Inc11,595New0.01%$0 MNov 10, 2026
99Simplicity Wealth,LLC10,980-6,458 (-37.03%)0.01%$0 MOct 23, 2026
100GAMCO Investors, Inc. Et Al10,0000 (0.00%)0.01%$0 MNov 12, 2026

All 130 institutional investors, with who bought and sold →

Mutual funds holding Codexis, Inc.#

117 funds hold shares worth $51 M (about 22.0% of the company). Since their previous reports 41 added shares and 28 sold, selling $3 M net.
Mutual funds holding Codexis, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 abrdn Healthcare Investorsabrdn Inc.4.44 M$10 M4.0%0.74%−21%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.2.63 M$6 M2.4%<0.01%no changeJun 30, 2026
🇺🇸 abrdn Life Sciences Investorsabrdn Inc.2.34 M$5 M2.1%0.77%−24%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors2.29 M$5 M2.1%<0.01%+3.0%Jun 30, 2026
🇺🇸 Columbia Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC2.66 M$4 M2.4%0.15%+6.4%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.895,869$2 M0.82%<0.01%+1.7%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors696,097$2 M0.64%0.01%+18%Jun 30, 2026
🇺🇸 Putnam Small Cap Value FundPutnam Investment Management, LLC492,703$1 M0.45%0.46%−6.9%May 31, 2026
🇺🇸 iShares Biotechnology ETFBlackRock Fund Advisors593,659$1 M0.54%0.01%−13%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC942,511$1 M0.86%<0.01%+6.7%Jul 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.458,168$1 M0.42%<0.01%+4.1%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC418,879$1 M0.38%<0.01%−0.1%May 31, 2026
🇺🇸 Columbia Variable Portfolio - Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC481,660$1 M0.44%0.24%−3.4%Jun 30, 2026
🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc.398,987$1 M0.36%0.05%+239%Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors290,804$1 M0.27%0.04%+31%Jun 30, 2026
🇺🇸 Large-Cap Growth PortfolioPacific Life Fund Advisors LLC213,439$0 M0.19%0.03%+5.9%Jun 30, 2026
🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc.316,606$0 M0.29%<0.01%+33%Jul 31, 2026
🇺🇸 Putnam VT Small Cap Value FundPutnam Investment Management, LLC185,697$0 M0.17%0.34%−4.9%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC147,202$0 M0.13%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC148,756$0 M0.14%<0.01%+11%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC120,049$0 M0.11%<0.01%+4.4%May 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC137,295$0 M0.13%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors130,110$0 M0.12%<0.01%+3.1%Jun 30, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.196,089$0 M0.18%<0.01%no changeJul 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC117,000$0 M0.11%0.18%no changeJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC183,067$0 M0.17%<0.01%no changeJul 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.107,077$0 M0.10%<0.01%+128%Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC92,542$0 M0.08%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.69,191$0 M0.06%0.01%+1.2%May 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC76,850$0 M0.07%<0.01%newJun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC74,090$0 M0.07%<0.01%+13%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC69,284$0 M0.06%0.01%+25%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC105,313$0 M0.10%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC52,039$0 M0.05%<0.01%−31%May 31, 2026
🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC98,404$0 M0.09%0.05%+49%Jul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation59,000$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC50,641$0 M0.05%0.01%+9.7%Jun 30, 2026
🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I40,867$0 M0.04%<0.01%−78%May 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.46,017$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC71,447$0 M0.07%<0.01%−9.7%Jul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.41,453$0 M0.04%<0.01%−62%Jun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC40,840$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company32,365$0 M0.03%<0.01%no changeMay 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.37,998$0 M0.03%<0.01%+15%Jun 30, 2026
🇺🇸 AVIP Fidelity Institutional AM Equity Growth PortfolioCONSTELLATION INVESTMENTS INC37,883$0 M0.03%0.03%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust28,868$0 M0.03%<0.01%newMay 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP56,705$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.33,021$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP52,788$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC30,376$0 M0.03%<0.01%+59%Jun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC29,493$0 M0.03%<0.01%newJun 30, 2026
🇺🇸 Clearwater Select Equity FundClearwater Management Co Inc.28,992$0 M0.03%0.01%newJun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC28,795$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC23,200$0 M0.02%<0.01%+12%May 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.45,863$0 M0.04%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC45,287$0 M0.04%<0.01%+25%Jul 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC27,054$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC41,308$0 M0.04%<0.01%+6.7%Jul 31, 2026
🇺🇸 Guardian Large Cap Fundamental Growth VIP FundPark Avenue Institutional Advisers LLC22,776$0 M0.02%0.03%no changeJun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC19,664$0 M0.02%<0.01%+12%Jun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors19,596$0 M0.02%<0.01%−24%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC19,608$0 M0.02%0.02%+19%Jun 30, 2026
🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS18,093$0 M0.02%0.02%no changeJun 30, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC17,822$0 M0.02%<0.01%−16%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS17,616$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC28,166$0 M0.03%<0.01%−0.8%Jul 31, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION13,961$0 M0.01%<0.01%no changeMay 31, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors16,710$0 M0.02%<0.01%−0.7%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.12,306$0 M0.01%<0.01%+11%May 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC13,414$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.12,386$0 M0.01%<0.01%−1.0%Jun 30, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP19,277$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC11,874$0 M0.01%<0.01%+32%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.11,736$0 M0.01%<0.01%+40%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC10,779$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC16,975$0 M0.02%<0.01%−18%Jul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC9,953$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC9,620$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.8,880$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS8,530$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management8,428$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.6,744$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC13,274$0 M0.01%<0.01%+8.0%Jul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC8,037$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC12,035$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC6,781$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC6,687$0 M<0.01%<0.01%+15%Jun 30, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.6,196$0 M<0.01%<0.01%−2.4%Jun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC9,973$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.9,730$0 M<0.01%<0.01%−3.5%Jul 31, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC5,744$0 M<0.01%<0.01%+14%Jun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC5,551$0 M<0.01%<0.01%−1.6%Jun 30, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC4,198$0 M<0.01%<0.01%+8.7%May 31, 2026
🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC5,038$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS6,619$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC3,320$0 M<0.01%<0.01%−39%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC3,283$0 M<0.01%<0.01%−40%May 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC6,396$0 M<0.01%<0.01%+30%Jul 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC3,667$0 M<0.01%<0.01%−53%Jun 30, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC3,534$0 M<0.01%<0.01%−18%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Codexis, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$943 K
17 sales, 6 insiders
Net, 12 months
-$943 K
open market only
Insiders on file
51
since
$5.5 M-$4.4 M$0Nov 2023: bought $0 (0 trades), sold $42 K (1 trades)Nov 23Sep 2024: bought $3.8 M (7 trades), sold $0 (0 trades)Oct 2024: bought $73 K (1 trades), sold $0 (0 trades)Dec 2024: bought $211 K (2 trades), sold $0 (0 trades)DecJan 2025: bought $283 K (2 trades), sold $0 (0 trades)Feb 2025: bought $647 K (4 trades), sold $0 (0 trades)Mar 2025: bought $1.0 M (7 trades), sold $0 (0 trades)MarApr 2025: bought $882 K (9 trades), sold $0 (0 trades)May 2025: bought $5.5 M (3 trades), sold $0 (0 trades)Jun 2025: bought $799 K (4 trades), sold $0 (0 trades)JunJul 2025: bought $536 K (4 trades), sold $0 (0 trades)Aug 2025: bought $2 K (1 trades), sold $0 (0 trades)Oct 2025: bought $0 (0 trades), sold $16 K (2 trades)OctNov 2025: bought $0 (0 trades), sold $4.4 M (15 trades)Dec 2025: bought $0 (0 trades), sold $423 K (2 trades)Jan 2026: bought $0 (0 trades), sold $8 K (1 trades)Jan 26Feb 2026: bought $0 (0 trades), sold $15 K (4 trades)Jun 2026: bought $0 (0 trades), sold $6 K (1 trades)Oct 2026: bought $0 (0 trades), sold $9 K (2 trades)OctNov 2026: bought $0 (0 trades), sold $13 K (2 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Codexis, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Alison MoorePresident and CEO, DirectorSell-10,651$1.137$12 K233,520Form 4
filed Raymond De VreDirectorSell-1,088$1.110$1 K83,723Form 4
filed Alison MoorePresident and CEO, DirectorSell-6,335$1.361$9 K244,171Form 4
filed Georgia ErbezSee RemarksSell-6,335$1.361—60,475Form 4
filed Raymond De VreDirectorSell-2,605$2.370$6 K84,811Form 4
filed Stefan LutzChief Scientific OfficerSell-5,862$1.130$7 K130,421Form 4
filed Georgia ErbezSee RemarksSell-3,826$1.310—66,810Form 4
filed Alison MoorePresident and CEO, DirectorSell-3,826$1.310$5 K250,506Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Codexis, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
4.4 M
4.9% of shares · 4.89 days to cover
Shares sold short, last 24 reportsAll stocks →

Fails to deliver

  • : 4,365 shares at $1.28
  • : 2,689 shares at $1.32
  • : 268 shares at $1.48
  • : 3,815 shares at $1.45
  • : 1,335 shares at $1.40

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Codexis, Inc. scorecard#

Passes 7 of the 22 checks that could be worked out: strongest in financial health (3 of 5), weakest in growth (1 of 6). Fiscal year 2025; market cap of Oct 26, 2026.

  • Valuation2 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median2.8×Price to book 2.8× against Biotechnology's median of 2.9×.
    • ✓Price to sales below its peers' median1.6×Price to sales 1.6× against Biotechnology's median of 8.7×.
    • ✗Free cash flow yield above 5%-17.0%Free cash flow is -17.0% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth1 of 6
    • ✓Revenue grew in the newest year18.6%Revenue up 18.6% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-20.2%-20.2% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-20.2%-20.2% a year against Biotechnology's median of 12.9% (181 companies).
    • ✗Earnings per share grew in the newest year-0.50 vs -0.89Diluted EPS -0.50 in fiscal 2025 against -0.89 the year before (report's currency).
    • ✗Net income higher than five years earlier-$44 M-$44 M in fiscal 2025 against -$24 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$44 MNet income -$44 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median-59.3%-59.3% against Biotechnology's median of -60.5% (243 companies).
    • ✗Return on equity above 15%-74.9%-74.9% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-59.3%-59.3% in fiscal 2025 against -25.2% in 2022.
  • Financial health3 of 5
    • ✓Short-term assets cover short-term liabilities3.8×Current ratio 3.82 at the end of fiscal 2025.
    • ✓Debt below equity0.8×Debt to equity 0.79 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $11 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-4.76Z-score -4.76 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year18.7%Diluted shares up 18.7% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Codexis, Inc.'s statements, beside the median of Biotechnology.

Codexis, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-59.3%-60.5%
Net margin-62.5%-68.9%
Return on equity-74.9%-61.0%
Revenue growth, 3 years a year-20.2%12.9%
Revenue growth18.6%15.8%
Debt to equity0.79×0.26×

4of 9on the Piotroski tests of financial strength

  • Net loss of $44 million, the 17th loss-making year in a row.
  • Free cash flow was negative: -$24 million.
  • The share count rose 18.7% in the year.
  • More cash than debt: net cash of $11 million.

Codexis, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Codexis, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue7059701391056968615049
Cost of revenue9.316133822141613149.8
Research and development52465980564434303022
Selling, general and administrative47555352493532292925
Operating expenses———————727357
Total costs and expenses1121181381731279381727357
Operating income−42−59−68−35−23−24−13−11−23−8.6
Interest and finance income2.63.74.21.40.50.41.30.70.10.1
Provision for credit losses——00.10.30.00———
Other non-operating income (expense)−4.8−10−120.11.1−0.2−0.7−0.3−0.1−0.1
Income before tax−44−65−76−33−21−24−12−11−23−8.6
Income tax0.00.00.10.30.20.30.0−0.00.1−0.0
Net income attributable to shareholders−44−65−76−34−21−24−12−11−23−8.6
Earnings per share, basic-0.50-0.89-1.12-0.51-0.33-0.40-0.21-0.21-0.50-0.21
Earnings per share, diluted-0.50-0.89-1.12-0.51-0.33-0.40-0.21-0.21-0.50-0.21
Shares, weighted average (basic)87736865655957———
Shares, weighted average (diluted)87736865655957524641
Balance sheet
Cash and cash equivalents511965r11411714990533119
Short-term investments27540———————
Receivables11191032r25r14r9.1r1211r5.9
Inventory1.81.82.72.01.21.00.40.61.00.8
Other current assets0.50.50.60.7r5.73.42.51.11.01.2
Current assets979993163162184114684527
Property, plant and equipment13141523219.76.34.82.82.2
Right-of-use (leased) assets312913394421240——
Goodwill2.52.52.53.23.23.23.23.23.23.2
Other intangible assets—————————0
Total assets148149137250246222149795436
Accounts payable1.62.85.93.23.03.02.63.13.54.2
Debt due within a year0—————————
Current liabilities25243649332515182512
Long-term debt40290—————0.30
Lease liabilities (non-current)302812384422250——
Total liabilities978250106825244232917
Retained earnings−607−563−498−421−388−366−342−330−315−292
Shareholders' equity516787145164170106562519
Total liabilities and equity148149137250246222149795436
Shares outstanding9082706665645954r4841
Cash-flow statement
Depreciation and amortization5.24.95.55.4——————
Share-based compensation9.61310.015127.76.97.97.15.7
Cash from operating activities−19−49−5311−14−16−13−14−8.8r−1.9r
Capital expenditure−4.5−4.3−4.4−8.3−14−3.7−3.7−2.8−1.0−0.9
Cash from investing activities24−57−4.9−14−21−5.7−3.7−2.8−1.0r−0.8r
Debt issued9.93000——————
Shares issued17318.700860r37240
Cash from financing activities28618.2−0.63.881543922−0.5
Change in cash32−46−49−2.9−3259382212r−3.2r
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Codexis, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Research and development revenue$44 M63%
  • Product revenue(total)$26 M37%

Countries and regions

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Codexis, Inc. operates: 6 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Codexis, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters3 offices$44 M62%
🇨🇳 China$9 M13%
🇮🇳 India$6 M8.1%
🇨🇭 Switzerland$4 M6.0%
🇮🇪 Ireland$1 M1.0%
🇸🇬 Singapore$0 M0.6%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Codexis, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$2.3 M
Stephen G. Dilly
Other top executives, average
$1.3 M
the CEO earned 1.8× this
$100 invested is now
$35
Codexis, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Stephen G. Dilly$2.3 M$921 K$1.3 M$35
2024Stephen G. Dilly$3.5 M$6.2 M$1.3 M$102
2023Stephen G. Dilly$3.1 M$1.2 M$1.9 M$65

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Codexis, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling

Auditor changed 1 · Restructuring 1 · Directors and officers 9 · Material agreement 1 · Agreement ended 1 · New debt 1 · Unregistered share sale 1 · Bylaws or fiscal year changed 1 · Shareholder vote 3 · Results announced 12

Codexis, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Material agreementAgreement endedNew debtUnregistered share sale8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
RestructuringDirectors and officersResults announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Directors and officersBylaws or fiscal year changed8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Auditor changed8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

Private share sales · funding history

Private share sales of Codexis, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2019$50 MPrivate placement after listing$50 to $250 million1equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Codexis, Inc.#

2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $120 K a year.

Certified, FY2026
2
#1,546 among companies on value.today
Worker positions
2
Median wage offered
$120 K
a year, full-time
Applications filed
3
Codexis, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Research Associate II, Upstream Bioprocess DevelopmentFood Scientists and Technologists1$95 K
Scientist IIBioinformatics Scientists1$146 K

Where: Redwood City, CA 2

Codexis, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202622$120 K3
FY202366$117 K9
FY202244$113 K5
FY202122$124 K2

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Codexis, Inc.

Layoffs at Codexis, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
283
2012–2025
Latest
46 people
2025-11-05
Codexis, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2025··········46·46
2023······59·····59
2012·······13345···178
Codexis, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
46 people (24% of workforce)Restructuring planSEC 8-K“In November 2025, Codexis eliminated 46 positions, or approximately 24% of its workforce.”Filing
Not statedRestructuring planSEC 8-KCompany-wide planFiling
25% of workforceRestructuring planSEC 8-K“As part of this enhanced strategic focus, the Company is streamlining operations, including discontinuing investment in certain development programs, primarily in Biotherapeutics, …”Filing
effective 31 peopleLayoffWARN noticeSan Carlos, CaliforniaNotice list
effective 28 peopleLayoffWARN noticeRedwood City, CaliforniaNotice list
45 peopleRestructuring planSEC 8-K“(the “Company”) committed to close its Singapore facility, which will include the termination of employment of approximately 45 employees at the Singapore facility.”Filing

Source: State WARN notices and SEC 8-K item 2.05

How Codexis, Inc. compares in Biotechnology

  • Market cap$140 M · higher than 40% of 726
  • Revenue$70 M · higher than 64% of 647
  • Net margin-21.8% · higher than 60% of 408
  • Revenue growth18.6% · higher than 60% of 438
  • Price / sales1.6× · lower than 89% of 339
  • Price / book2.8× · lower than 51% of 534
  • FCF yield-17.0% · higher than 48% of 449

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Codexis, Inc.🇺🇸$140 M—-21.8%+18.6%
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 26, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikidata, Wikipedia, Wikimedia Commons, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Codexis, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Codexis, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Codexis, Inc.? Suggest a correction